ResearcherFred and Pamela Buffett Cancer CenterActive in the last 2 years

Junyi Lin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0004-4962-0814; OpenAlex author ID A5101973527. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 2 papers

Papers 2

Smart polymeric nanoparticles for targeted delivery and microenvironment-responsive therapy in pancreatic cancer. First author DOI 10.1016/j.smaim.2025.09.003 ↗
Modulating immune cells within pancreatic ductal adenocarcinoma via nanomedicine. Co-author DOI 10.1042/ebc20243001 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jingjing Sun · 2 shared papers, 2025 · strength 0.71
- Paper Modulating immune cells within pancreatic ductal adenocarcinoma via nanomedicine. DOI 10.1042/ebc20243001 ↗
- Paper Smart polymeric nanoparticles for targeted delivery and microenvironment-responsive therapy in pancreatic cancer. DOI 10.1016/j.smaim.2025.09.003 ↗
Ying Li · 2 shared papers, 2025 · strength 0.71
- Paper Modulating immune cells within pancreatic ductal adenocarcinoma via nanomedicine. DOI 10.1042/ebc20243001 ↗
- Paper Smart polymeric nanoparticles for targeted delivery and microenvironment-responsive therapy in pancreatic cancer. DOI 10.1016/j.smaim.2025.09.003 ↗
Narayani Prasad Kar · 1 shared paper, 2025 · strength 0.28
- Paper Smart polymeric nanoparticles for targeted delivery and microenvironment-responsive therapy in pancreatic cancer. DOI 10.1016/j.smaim.2025.09.003 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.